Literature DB >> 21717592

A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study.

Ana B Galván1, Marta Salido, Blanca Espinet, José Placer, Lara Pijuan, Núria Juanpere, Josep Lloreta, Francesc Solé, Antoni Gelabert-Mas.   

Abstract

BACKGROUND: Non-muscle-invasive urothelial cell carcinoma (NMIUCC) has a high tendency to recur and affected patients must be monitored regularly using invasive cystoscopies. The aim of the current study was to compare a multicolor fluorescence in situ hybridization (FISH) assay (UroVysion) with routine follow-up (cystoscopy and cytology) in the monitoring of patients with a previous history of NMIUCC.
METHODS: An unselected cohort of patients under surveillance for a previous history of NMIUCC was prospectively studied. A total of 248 examinations in 223 patients were analyzed. Each exploration was comprised of cytological and FISH microscopic examination of voided urine samples and cystoscopy. The sensitivity, specificity, and positive (PPV) and negative (NPV) predictive values for tumor recurrence of all 3 techniques were determined.
RESULTS: The sensitivities of FISH and cystoscopy were not found to be significantly different (92.9% and 82.1%, respectively). The specificities of FISH and cystoscopy were 92.7% and 89.7%, respectively. The PPV and NPV of FISH were 53.5% and 97.2%, respectively, whereas those of cystoscopy were 63.4% and 98.9%, respectively. No significant differences were found between these 2 tests. In contrast, the sensitivity and specificity of cytology were 14.3% and 99.5%, respectively.
CONCLUSIONS: Given the lack of statistically significant differences with regard to FISH and cystoscopy results, the authors propose that FISH could be a useful monitoring tool in the surveillance of patients with a previous history of NMIUCC.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21717592     DOI: 10.1002/cncy.20168

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  11 in total

Review 1.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.

Authors:  Philip H Kim; Ranjit Sukhu; Billy H Cordon; John P Sfakianos; Daniel D Sjoberg; A Ari Hakimi; Guido Dalbagni; Oscar Lin; Harry W Herr
Journal:  BJU Int       Date:  2014-02-14       Impact factor: 5.588

3.  Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancer.

Authors:  Makito Miyake; Takuya Owari; Shunta Hori; Kiyohide Fujimoto
Journal:  Transl Androl Urol       Date:  2019-07

4.  Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.

Authors:  Haythem Dimashkieh; Daynna J Wolff; T Michael Smith; Patricia M Houser; Paul J Nietert; Jack Yang
Journal:  Cancer Cytopathol       Date:  2013-06-25       Impact factor: 5.284

Review 5.  Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.

Authors:  Aadel A Chaudhuri; Bruna Pellini; Nadja Pejovic; Pradeep S Chauhan; Peter K Harris; Jeffrey J Szymanski; Zachary L Smith; Vivek K Arora
Journal:  JCO Precis Oncol       Date:  2020-07-15

6.  [Non-muscle-invasive high-grade bladder cancer].

Authors:  G Gakis; A Stenzl; T Horn; J E Gschwend; W Otto; M Burger
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

7.  Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.

Authors:  Amir Hossein Aalami; Farnoosh Aalami
Journal:  Int J Clin Oncol       Date:  2022-07-18       Impact factor: 3.850

8.  Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization.

Authors:  Zunfu Ke; Yuanhua Lai; Xudong Ma; Shuhua Lil; Wenhua Huang
Journal:  Oncol Lett       Date:  2013-12-09       Impact factor: 2.967

9.  A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection.

Authors:  Hugh J Lavery; Boriana Zaharieva; Andrew McFaddin; Nyla Heerema; Kamal S Pohar
Journal:  BMC Cancer       Date:  2017-04-07       Impact factor: 4.430

10.  Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer.

Authors:  Elin Andersson; Kenneth Steven; Per Guldberg
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.